Health & Fitness Walmart and Walgreens begin rolling out Moderna and J&J boosters
JCVI announces only 500,000 Brits should get Covid booster vaccines
Between 400,000 and 500,000 of the most vulnerable UK patients - including those with leukemia, HIV and organ transplant patients - will be made eligible for the top-up doses.Between 400,000 and 500,000 of the most vulnerable patients — including those with leukemia, HIV and organ transplant patients — will be made eligible for the top-up doses when the rollout expands in the coming days.
Walgreens Boots Alliance Inc and Walmart Inc said on Friday that their U.S. pharmacies have started administering booster shots of the Moderna and Johnson & Johnson COVID-19 vaccines.
It comes one day after the Centers for Disease Control and Prevention (CDC) approved both companies' extra doses following the recommendations of its advisory committee.
The health agency also allowed fully vaccinated Americans be able to 'mix and match' Covid vaccines and booster shots.
This means people can receive a booster made by a company that is different than the one that made the vaccine they initially received.
Pressure mounts for boosters as Scotland's Covid admissions rise 50%
Some 114 Covid patients were admitted to hospital in Scotland the week up to September 1, compared to a seven-day rolling average of 76 on August 24.Data from the Government's Covid dashboard showed that on average there were 114 patients being admitted each day to hospitals in Scotland in the week to September 1, compared to 76 the week prior.
In addition to the Pfizer-BioNTech booster shots that began rolling out last month, it means as many as 100 million Americans may be eligible to get an extra dose.
Walmart and Sam's Club pharmacies are ready to administer all three authorized booster shots, Walmart. said.
Meanwhile CVS Health Corp told Reuters that booster shots of Moderna's vaccine were available at select stores, but not J&J's.
In August, the company stopped offering J&J shots at its pharmacies after reports that the one-shot vaccine was linked to side effects including rare blood clots and a rare autoimmune disorder than can lead to temporary paralysis.
Early Moderna vaccine recipients twice as likely to contract Covid
Moderna Inc says people who received its COVID-19 vaccine last year are nearly twice as likely to get a breakthrough infection compared to those recently vaccinated. Breakthrough cases occur when people contract the disease 14 days or more after receiving their final dose of the shot.New data published on Wednesday found 88 breakthrough cases of COVID-19 among Americans vaccinated from December 2020 to March 2021.Comparatively, there were 162 cases - 1.8 times as many - among those vaccinated between July 2020 and December 2020.
'We will provide Moderna or Pfizer-BioNTech vaccine booster shots to eligible individuals who received the Johnson & Johnson (Janssen) vaccine as their primary vaccination,' a CVS spokesperson said on Friday.
Rite Aid Corp did not immediately respond to Reuters request for comment on their plans to roll out J&J and Moderna vaccine boosters.
U.S. health regulators have recommended a second dose of J&J's single-dose COVID-19 vaccine for 18-year-olds and above who received the first shot at least two months earlier.
It came after the company published data in September looking at the effectiveness of a second dose given 56 days after the first in adults 18 and older.
Video: U.S. FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boost (Reuters)
Results showed a booster shot was 94 percent effective against symptomatic COVID-19 and 100 percent effective against critical illness at least 14 days post-vaccination.
Covid? What Covid? Moderna boss expects pandemic to be done in a year
Moderna's chief executive Stéphane Bancel said there will be enough jabs to vaccinate the world's 8billion people by the middle of next year and he expects a return to normal by this time in 2022.Moderna's chief executive Stéphane Bancel said enough jabs will have been made to vaccinate all of the world's 7.7billion people by the middle of next year.
This compares to 70 percent protection seen with a single dose.
There was only one case of COVID-19 in the vaccine group and 14 in the placebo group.
J&J said that a booster given two months after the first dose increased antibody levels between four-fold and six-fold.
When given six months after the first dose, antibody levels shot up nine-fold after one week and 12-fold after four weeks.
Health officials also recommended a third shot of Moderna's two-dose vaccine six months after the second dose for people aged at least 65 and those at high risk of severe disease and exposure to the virus through their jobs.
The company presented data at the CDC's advisory committee meeting on Thursday showing a booster raised antibody levels between 23-fold and 44-fold.
The firm also revealed that people who received its COVID-19 vaccine last year are nearly twice as likely to get a breakthrough infection compared to those recently vaccinated.
Finland pauses use of Moderna COVID-19 vaccine in young people
Finland has joined neighboring Sweden and Denmark in pausing the use of the Moderna COVID-19 vaccine in some young people. Males under 30 will now receive the Pfizer shot as well.The Finnish Institute for Health and Welfare said on Thursday that authorities won't give the vaccine to males under age 30, and they will be offered the Pfizer-BioNTech immunization instead.
There were 88 breakthrough cases of COVID-19 among Americans vaccinated from December 2020 to March 2021.
Comparatively, there were 162 cases - 1.8 times as many - among those vaccinated between July 2020 and December 2020.
The Cambridge, Massachusetts-based company said the data provided evidence for giving booster doses to fully vaccinated people.
The FDA and CDC last month signed off on booster shots of the COVID-19 vaccine from Pfizer for the same groups as for Moderna.
U.S. pharmacy chains including Walgreens, Rite Aid and CVS began administering booster doses of Pfizer's shot at their stores on September 24.
About 11.6 million people have received additional doses of Pfizer-BioNTech and Moderna vaccines since August 13, when immunocompromised Americans started receiving additional doses, CDC data show.
Moderna defends its vaccine after recent heart inflammation concerns .
Moderna officials are standing by its Covid shot after seven European countries sidelined it for the Pfizer jab instead in young people. There are concerns the jab causes myocarditis.Seven European nations have either restricted the use of the shot in adults under age 30 or have made a recommendation against its use, in recent weeks.